Abu Dhabi’s Department of Health (DoH) and Biocom California establish a new life sciences partnership intended to strengthen links between Abu Dhabi and California. Announced on June 23, 2026, the initiative is presented as a strategic “corridor” connecting the healthcare and life sciences ecosystems across the two locations. Biocom California is described as a major life sciences association representing more than 1,800 biotechnology, pharmaceutical and related organizations.
Under the announcement, DoH is identified as the healthcare regulator for Abu Dhabi, indicating that the partnership is positioned within Abu Dhabi’s regulatory and healthcare framework. The release frames the effort as a platform to support engagement between stakeholders in the life sciences sector, though it does not specify detailed program components such as funding amounts, timelines, or named project partners in the provided text.
Across the available material, the key reported elements are the parties involved (DoH Abu Dhabi and Biocom California), the date and location of the announcement, and the purpose of building stronger collaboration between the Abu Dhabi and California life sciences communities.
